Products and Services: What We Do

We are a development-stage company that intends to become a leading specialized medical device supplier and cytology and molecular diagnostics laboratory, focused exclusively on breast cancer. We will market our MASCT™ System (Mammary Aspirate Specimen Cytology Test) for the collection of Nipple Aspirate Fluid (NAF). The MASCT System is a patented, FDA-cleared medical device and patient sample collection kit. The FDA was notified, from clinical trial data, that the MASCT System can be used to collect NAF for cytology testing in the determination and/or differentiation of normal versus premalignant versus malignant cells

We intend to market the MASCT System to physicians and clinics that specialize in women’s health, including mammography clinics, dedicated Breast Health Clinics, and Obstetrics/Gynecology medical practices through a dedicated marketing and sales force. The collected NAF samples will be sent to a CLIA-certified laboratory that we will establish.

Because NAF samples are among the smallest medical samples handled by clinical laboratories, specialized procedures, protocols, and equipment will be used to maximize the diagnostic value of each sample. Using both conventional cytology and advanced molecular diagnostic technologies, we intend to deliver accurate and comprehensive diagnostic reports.